1
|
Abstract
Current research on factors affecting the welfare of dairy calves is predominantly based on indoor, year-round calving systems. Calf rearing in these systems differs from that in more seasonal, pasture-based dairy production, meaning that risks to the welfare of dairy calves may not always be comparable between the two systems. The aim of this review was to consolidate the scientific literature relating to calf welfare in pasture-based dairy systems from birth until weaning, allowing for (1) the identification of current and emerging risks to calf welfare and (2) the formation of recommendations to mitigate these risks. Many of the risks to calf welfare discussed in this review are not exclusive to pasture-based dairies. This includes a global trend for increasing perinatal mortalities, a significant number of calves failing to achieve effective passive transfer of immunity, the low uptake of best practice pain relief when calves are disbudded, and the feeding of restricted milk volumes. In addition to these persisting welfare risks, two factors discussed in this review pose an immediate threat to the social license of dairy farming; the separation of cow and calf soon after birth and the management of surplus calves (i.e. calves not needed by the dairy industry). Several recommendations are made to improve the uptake of best-practice calf rearing and progress the development of alternative pasture-based rearing systems that accommodate changing community expectations. These include communication strategies that strengthen farmer beliefs regarding the welfare and productivity benefits achieved by best practice calf rearing and challenge beliefs regarding the associated costs. Farmers should also be encouraged to benchmark their rearing practices through improved record keeping of key rearing inputs and outcomes. Biological research is needed to advise the development of new calf rearing recommendations and the evolution of existing recommendations. Research priorities identified by this review include the effects of dystocia on the neonate and strategies to mitigate these effects, relationships between features of pen design and calf health and welfare, feasibility of dam rearing in large pasture-based dairy systems, and strategies that increase the value of the surplus calf.
Collapse
|
2
|
Tschoner T. Methods for Pain Assessment in Calves and Their Use for the Evaluation of Pain during Different Procedures-A Review. Animals (Basel) 2021; 11:1235. [PMID: 33922942 PMCID: PMC8146443 DOI: 10.3390/ani11051235] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Revised: 04/21/2021] [Accepted: 04/22/2021] [Indexed: 01/19/2023] Open
Abstract
The evaluation and assessment of the level of pain calves are experiencing is important, as the experience of pain (e.g., due to routine husbandry procedures) severely affects the welfare of calves. Studies about the recognition of pain in calves, and especially pain management during and after common procedures, such as castration, dehorning, and disbudding, have been published. This narrative review discusses and summarizes the existing literature about methods for pain assessment in calves. First, it deals with the definition of pain and the challenges associated with the recognition of pain in calves. Then it proceeds to outline the different options and methods for subjective and objective pain assessment in calves, as described in the literature. Research data show that there are several tools suitable for the assessment of pain in calves, at least for research purposes. Finally, it concludes that for research purposes, various variables for the assessment of pain in calves are used in combination. However, there is no variable which can be used solely for the exclusive assessment of pain in calves. Also, further research is needed to describe biomarkers or variables which are easily accessible in the field practice.
Collapse
Affiliation(s)
- Theresa Tschoner
- Clinic for Ruminants with Ambulatory and Herd Health Services, Centre for Clinical Veterinary Medicine, LMU Munich, Sonnenstrasse 16, 85764 Oberschleissheim, Germany
| |
Collapse
|
3
|
Sheil M, Chambers M, Polkinghorne A, Sharpe B. Topical Application of Lidocaine and Bupivacaine to Disbudding Wounds in Dairy Calves: Safety, Toxicology and Wound Healing. Animals (Basel) 2021; 11:ani11030869. [PMID: 33803728 PMCID: PMC8003238 DOI: 10.3390/ani11030869] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Revised: 03/14/2021] [Accepted: 03/16/2021] [Indexed: 02/08/2023] Open
Abstract
Simple Summary Disbudding is a common, but painful procedure performed on calves to prevent horn growth. Tri-Solfen® is a combination local anaesthetic and antiseptic formulation which, applied topically to the disbudding wound, is reported to reduce calf pain. Applied in this manner, the local anaesthetics in Tri-Solfen®, lidocaine and bupivacaine, are reported to be poorly absorbed, resulting in low risk of neurological or cardiotoxic effects. The potential impacts on other blood, urine and tissue parameters and on wound healing when used in this manner, and/or accidental overdose situations are unknown, however. We performed experiments investigating (i) the safety of Tri-Solfen® (including overdose situations) and (ii) the impact of Tri-Solfen® on disbudding wound healing under field conditions. No adverse health effects were observed in Tri-Solfen®-treated animals, even those receiving 5× the recommended dose, with no clinically significant differences in measured parameters between placebo and Tri-Solfen® groups. No negative impacts on wound healing were noted. Conversely, lower levels of bacterial wound colonisation were evident, and there was reduced incidence of abnormal wounds at days 11–12 in Tri-Solfen®-treated animals. Abstract Tri-Solfen® is a combination topical anaesthetic and antiseptic solution containing lidocaine, bupivacaine, adrenaline and cetrimide. Applied to wounds, it is reported to reduce the pain experienced by calves following thermocautery disbudding. While lidocaine and bupivacaine are widely used in medicine, conflicting data exist on the impact of these compounds when applied directly to the surgical wound. To investigate the safety of Tri-Solfen® applied to thermocautery disbudding wounds of calves, experiments were performed to measure (i) the safety of Tri-Solfen® (including in overdose situations); and (ii) the impact of Tri-Solfen® application at recommended doses on disbudding wound healing under field conditions. Haematological, biochemical and urinalysis parameters did not show clinically significant differences between placebo and Tri-Solfen® groups (1×, 3× and 5× dose). No adverse health impacts were reported. Histopathological analysis of wounds noted a reduction in bacterial colonies in Tri-Solfen®-treated wounds. Under field conditions, no negative impacts on wound healing were noted. Conversely, there was reduced incidence of abnormal wounds, with an associated trend toward improved average daily gain at days 11–12 in Tri-Solfen®-treated animals. These data are considered to support the safety of topical anaesthesia, as formulated in Tri-Solfen®, to the thermocautery disbudding wound in calves.
Collapse
Affiliation(s)
- Meredith Sheil
- Animal Ethics Pty. Ltd., Yarra Glen 3775, Australia
- Correspondence:
| | | | - Adam Polkinghorne
- Department of Microbiology and Infectious Diseases, NSW Health Pathology, Nepean Blue Mountains Pathology Service, Penrith 2751, Australia;
- Nepean Clinical School, Faculty of Medicine and Health, University of Sydney, Kingswood 2747, Australia
| | - Brendan Sharpe
- Invetus Pty. Ltd., Armidale 2350, Australia; (M.C.); (B.S.)
| |
Collapse
|
4
|
Reedman CN, Duffield TF, DeVries TJ, Lissemore KD, Duncan IJ, Winder CB. Randomized controlled trial assessing the effects of xylazine sedation in 2- to 6-week-old dairy calves disbudded with a cautery iron. J Dairy Sci 2021; 104:5881-5897. [PMID: 33685706 DOI: 10.3168/jds.2020-19689] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Accepted: 01/01/2021] [Indexed: 11/19/2022]
Abstract
The use of local anesthesia and a nonsteroidal anti-inflammatory drug (NSAID) can reduce indicators of pain and inflammation and encourage self-rewarding behavior in calves following disbudding. Although the use of sedation may be recommended as a best practice for disbudding, there is little research in this area. The objective of this study was to evaluate the effects of xylazine sedation in conjunction with a local anesthetic and an NSAID in calves undergoing cautery disbudding. One hundred twenty-two group-housed female and male Holstein calves fed milk with automated feeders, aged 13 to 44 d, were enrolled over 9 replicates and randomly allocated to 1 of 2 treatments: (1) sedated: lidocaine cornual nerve block, 0.5 mg/kg meloxicam (administered subcutaneously) and 0.2 mg/kg xylazine (administered intramuscularly), or (2) nonsedated: lidocaine cornual nerve block and meloxicam. Outcomes collected consisted of feeding behavior (collected using automated milk feeders), latency to drink milk following disbudding, play behavior (induced by adding bedding), lying behavior, mechanical nociceptive threshold (MNT, measured using a pressure force algometer), struggling behavior during disbudding, length of time to administer the nerve block, length of time to disbud, and serum haptoglobin concentrations. Data were analyzed using mixed models with a fixed effect for baseline values and a random effect for trial replicate. Linear regression was used to assess continuous outcomes, logistic regression for binary outcomes, and Poisson and negative binomial models for count data with negative binomial models used if the over dispersion term was significant. There were no detected differences between the treatment groups in mean daily milk consumption in the 72-h following disbudding. Sedated calves had reduced average milk drinking speed from 0 to 24 h and 24 to 48 h following disbudding compared with nonsedated calves, but no difference was detected from 48 to 72 h. Sedated calves had reduced MNT at 0, 60, and 240 min after disbudding, but no differences were detected between groups at 24 h after disbudding. Nonsedated calves had 4.5 times the odds (95% CI: 1.5-13.2) of struggling more than twice during the disbudding procedure compared with sedated calves, and it took less time to administer a nerve block to sedated calves compared with nonsedated. At +3 h, nonsedated calves were 79 times (95% CI: 22.4 to 279.2) more likely to play compared with sedated calves, and 24 h after disbudding, sedated calves were 2 times more likely to play compared with nonsedated calves (95% CI: 0.93-4.3). The results indicate that calves sedated with xylazine for cautery disbudding responded less to painful stimuli (disbudding and MNT) both during and following the procedure and had a higher rate of play behavior 24 h following sedation compared with the nonsedated calves, but xylazine may also have a prolonged carryover effect that affects suckling behavior for 48 h following sedation.
Collapse
Affiliation(s)
- Cassandra N Reedman
- Department of Population Medicine, University of Guelph, Guelph, Ontario, N1G 2W1 Canada.
| | - Todd F Duffield
- Department of Population Medicine, University of Guelph, Guelph, Ontario, N1G 2W1 Canada
| | - Trevor J DeVries
- Department of Animal Biosciences, University of Guelph, Guelph, Ontario, N1G 2W1 Canada
| | - Kerry D Lissemore
- Department of Population Medicine, University of Guelph, Guelph, Ontario, N1G 2W1 Canada
| | - Ian J Duncan
- Department of Animal Biosciences, University of Guelph, Guelph, Ontario, N1G 2W1 Canada
| | - Charlotte B Winder
- Department of Population Medicine, University of Guelph, Guelph, Ontario, N1G 2W1 Canada
| |
Collapse
|
5
|
Wagner BK, Nixon E, Robles I, Baynes RE, Coetzee JF, Pairis-Garcia MD. Non-Steroidal Anti-Inflammatory Drugs: Pharmacokinetics and Mitigation of Procedural-Pain in Cattle. Animals (Basel) 2021; 11:282. [PMID: 33499412 DOI: 10.3390/ani11020282] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2020] [Revised: 01/17/2021] [Accepted: 01/18/2021] [Indexed: 11/17/2022] Open
Abstract
Common routine management practices in cattle, such as castration and disbudding, are recognized as being painful. In the United States (U.S.), these procedures are frequently performed without pain mitigation and there are currently no drugs federally approved for such use. Non-steroidal anti-inflammatory drugs, such as meloxicam, flunixin meglumine and aspirin, are the most commonly used analgesics in U.S. food-animal production systems. However, the body of research investigating the effectiveness of these pharmaceuticals to control pain in cattle at castration and disbudding has not been comprehensively evaluated. Therefore, this review examined existing literature to summarize meloxicam, flunixin and aspirin (1) pharmacokinetics (PK) and (2) administration outcome in regard to pain control during castration and disbudding procedures, in cattle. Following systematic searches and screening, 47 PK and 44 publications were extracted for data and are presented. The sample size contained notable variability and a general deficiency of validated and replicated methodologies for assessing pain in cattle remain substantial challenges within this research area. Future research should prioritize replication of pain assessment methodologies across different experimental conditions to close knowledge gaps identified by the present study and facilitate examination of analgesic efficacy.
Collapse
|
6
|
Sahebjam F, Kongara K, Chambers JP, Walker RE, Naffa R, Lopez-Villalobos N, Singh PM. Pressure Algometry Validation and Determination of Efficacy of Articaine Hydrochloride Ring Block in Antler Removal in Red Deer ( Cervus elaphus). Animals (Basel) 2020; 10:E2023. [PMID: 33153106 DOI: 10.3390/ani10112023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2020] [Revised: 10/29/2020] [Accepted: 10/31/2020] [Indexed: 11/28/2022] Open
Abstract
Simple Summary Red deer (Cervus elaphus) are farmed in New Zealand for the production of velvet antler. Velvet is harvested as living antler tissue, and currently lignocaine is the only licensed local anaesthetic approved for deer antler removal in New Zealand. The use of lignocaine is not without consequences, including drug residues in harvested velvet antler tissue and its short acting analgesic effect. This study was designed to determine the effect of local anaesthetic, articaine hydrochloride as an alternative treatment and to establish the baseline measurements of mechanical nociceptive threshold in 40 male yearling red deer. Ten of the forty enrolled deer were selected for the articaine efficacy study. The mechanical nociceptive thresholds were measured using a handheld algometer applied at 4 points; the cranial, medial, caudal and lateral aspects of the base of each antler. The force applied, which resulted in a movement by the animal, was recorded in newtons (N). This study showed that nociceptive threshold response in deer could be reliably measured, and articaine proved to be a promising alternative for velveting the deer antlers. Abstract New Zealand deer farming centres on the production of meat and velvet antler. Velvet antler removal is a painful procedure and currently, New Zealand Animal Welfare regulations dictate surgical removal of velvet antlers under lignocaine anaesthesia. To improve our knowledge on the efficacy and duration of other local anaesthetics to mitigate pain after antler removal, it is important to accurately assess and quantify pain arising from antler removal. Therefore, the current study was designed to validate mechanical nociceptive threshold (MNT) testing using a Wagner hand-held algometer, and to apply this methodology to assess the efficacy and duration of action of articaine for antler removal in deer. Baseline force (N) required to elicit the nociceptive response was recorded in 40 yearling male red deer on three alternate days. Ten of the 40 animals were selected for antler removal after administration of 4% articaine hydrochloride as a ring block. The duration of analgesic efficacy of articaine was assessed by algometry across 5 time points. There was a significant difference in MNTs among the three days (day 3 versus day 1 (p < 0.0001), day 2 versus day 1 (p < 0.0001), and day 1 versus day 2 (p < 0.01)). Positive correlations were observed between weight, antler length and thresholds. The MNT values remained above 20N for 6 h after removal of velvet antlers under the articaine ring block. This study provides valuable information about the use of MNT in red deer. These findings lay a foundation for future studies in the topics of peri-operative and postoperative pain management in deer antler removal, and a possible alternative use for articaine.
Collapse
|
7
|
Abstract
Aims To compare wound healing 7 days after cautery disbudding of dairy calves treated immediately after disbudding with a traditional antimicrobial spray (OXY) or with a topical anaesthetic gel containing cetrimide, adrenaline and two local anaesthetics, lignocaine and bupivacaine (TA). Method Eighty-one female dairy calves between 6-8 weeks of age were disbudded using a standard cautery disbudding protocol (sedation, cornual block, and analgesia), with complete removal of the horn bud. After disbudding, the wound on the right and left horn buds within each animal were randomly allocated to receive either OXY or TA. One week after disbudding, wounds were visually assessed for the presence of exudate, necrotic tissue, crust, or granulation tissue which were each assigned a grade from 1-3, where 1 = no evidence, 2 = moderate presence; and 3 = marked presence. Results At 7 days after disbudding, the prevalence of wounds with exudate or necrotic tissue was very low, and independent of treatment. The odds of a disbudding wound treated with TA being scored as having granulation tissue and was 5.2 (95% CI = 1.72-15.7) times that of a wound treated with OXY. Conversely, the odds of wounds treated with TA being scored as having crusts was 0.18 (95% CI = 0.06-0.57) that of a wound treated with OXY. No sign of infection was seen in any calves. Conclusion and clinical relevance The greater prevalence of granulation tissue and reduction in crusting in disbudding wounds treated with topical anaesthetic gel compared to those treated with the antimicrobial spray suggests that use of the topical anaesthetic gel may speed wound healing compared to using antimicrobial spray. This should be further tested in a larger study undertaken over a longer period.
Collapse
Affiliation(s)
- G Stilwell
- School of Veterinary Science, Massey University, Palmerston North, New Zealand
| | - R A Laven
- School of Veterinary Science, Massey University, Palmerston North, New Zealand
| |
Collapse
|
8
|
Sheil ML, Chambers M, Sharpe B. Topical wound anaesthesia: efficacy to mitigate piglet castration pain. Aust Vet J 2020; 98:256-263. [PMID: 32096229 PMCID: PMC7384076 DOI: 10.1111/avj.12930] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2019] [Revised: 01/25/2020] [Accepted: 01/28/2020] [Indexed: 11/29/2022]
Abstract
OBJECTIVE There is a critical need for safe and effective analgesic treatments to address pain resulting from surgical husbandry procedures in livestock. Piglet castration results in acute pain and stress to the animal; however, it is performed globally on millions of piglets annually, often without any analgesia what-so-ever. Tri-Solfen® (Animal Ethics Pty Ltd, Yarra Glen, Victoria, Australia) is a combination local anaesthetic and antiseptic formulation which, applied topically to wounds, has proven effective, and is registered for use to alleviate pain associated with castration (and other wounds) in lambs and calves in Australia and New Zealand. It is also reported to be effective to reduce pain in piglets following castration. DESIGN This randomised, blinded, placebo-controlled study examined the safety and efficacy of the formulation, administered via an adapted wound instillation method, to control pain both during and following piglet castration. METHOD Piglets received Tri-Solfen or placebo, instilled to the wound immediately following skin incision. A 30 s wait period was then observed prior to completing castration. Pain mitigation was assessed by grading nociceptive resistance movements and piglet vocal response during castration, as well as by grading response to mechanical sensory stimulation of the wound (von Frey and needlestick) following castration. RESULTS There was a significant reduction in nociceptive motor and vocal response during castration and in response to mechanical sensory wound stimulation up to and including 2 h following castration. There were no adverse events. CONCLUSION Administered via this method, Tri-Solfen is effective to mitigate acute peri-operative castration pain in piglets.
Collapse
Affiliation(s)
- ML Sheil
- Animal Ethics Pty LtdYarra GlenVictoria3775Australia
| | - M Chambers
- Invetus Pty LtdArmidaleNew South Wales2350Australia
| | - B Sharpe
- Invetus Pty LtdArmidaleNew South Wales2350Australia
| |
Collapse
|